San Diego-based Aethlon Medical Inc., a medical device company that offered its blood purifier device to treat an Ebola patient in Germany, announced that the hospital reported the patient “virus free.”

The patient, a World Health Organization worker, contracted the virus in Sierra Leone. The Ugandan doctor was being treated at the Frankfurt University Hospital in Germany when Aethlon offered its biofiltration device, the Hemopurifier, for treatment.

The device was fitted into a dialysis machine, which filters blood for people with kidney disease. In the case of Ebola, the device removes viruses, plus the proteins that suppress the immune system, from the bloodstream, according to Jim Joyce, CEO and founder of Aethlon (NASDAQ:OTCQB:AEMD).

At present, no antiviral therapy or vaccine has proven to be effective against Ebola virus infection in humans. According to the World Health Organization, more than 5,000 deaths have been attributed to the current Ebola virus epidemic. The patient at Frankfurt University Hospital was administered Hemopurifier therapy through special approval from the Federal Institute for Drugs and Medical Devices, an independent federal higher authority within the portfolio of the Federal Ministry of Health of Germany.

"It is truly wonderful that the patient, who was reported to be suffering from multiple organ failure, is now recovering from Ebola infection," Joyce said. "In the coming days, we will disclose the venue of a public presentation that will report treatment data including the quantification of viral load reduction and viruses captured by our Hemopurifier during the treatment of this patient."